# A Prospective, Multi-site, Randomized, Sham-Controlled, Double-Blind Trial With One-Way Crossover Designed to Assess the Effectiveness and Safety of the Gimer NeuroBlock SCS Trialing System for the Treatment of Chronic Back Pain and/or Lower Limb Pain

> **NCT04693650** · NA · COMPLETED · sponsor: **GiMer Medical** · enrollment: 22 (actual)

## Conditions studied

- Chronic Pain
- Low Back Pain
- Lower Limb Pain

## Interventions

- **DEVICE:** NeuroBlock UHF stimulation

## Key facts

- **NCT ID:** NCT04693650
- **Lead sponsor:** GiMer Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04693650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04693650, "A Prospective, Multi-site, Randomized, Sham-Controlled, Double-Blind Trial With One-Way Crossover Designed to Assess the Effectiveness and Safety of the Gimer NeuroBlock SCS Trialing System for the Treatment of Chronic Back Pain and/or Lower Limb Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04693650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*